Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Dec 2025 07:00 AM
RNS
TR-1
24 Nov 2025 07:00 AM
RNS
Expansion of Senior Finance Leadership Team
20 Nov 2025 07:00 AM
RNS
Portfolio Update
30 Sep 2025 07:00 AM
RNS
Interim Results and Investor Presentation
22 Sep 2025 07:00 AM
RNS
Asset Purchase Agreement with Destiny Pharma
18 Sep 2025 07:00 AM
RNS
Notice of Interim Results
30 Jun 2025 12:22 PM
RNS
Result of AGM
30 Jun 2025 07:00 AM
RNS
Office move and Related Party Transaction
27 Jun 2025 07:00 AM
RNS
Q-Bot Limited Fundraising
10 Jun 2025 01:28 PM
RNS
TR-1
06 Jun 2025 03:12 PM
RNS
Notice of AGM and Annual Report & Accounts
04 Jun 2025 02:34 PM
RNS
Director/PDMR Shareholding
04 Jun 2025 07:00 AM
RNS
Preliminary results for the year ended 31 Dec 2024
14 May 2025 04:02 PM
RNS
PDS: Q1 Results and Clinical and Corporate Update
09 May 2025 10:30 AM
RNS
TR-1
27 Mar 2025 04:46 PM
RNS
PDS: Q4 Results and Clinical Programs Update
07 Mar 2025 04:26 PM
RNS
PDS: VERSATILE-003 Phase 3 Clinical Trial
27 Feb 2025 04:30 PM
RNS
PDS: up to $22mn Registered Direct Offering
05 Feb 2025 03:24 PM
RNS
PDS Biotech reaffirms guidance for clinical trial
03 Feb 2025 07:00 AM
RNS
ProAxsis: Status Update and Proposed Fundraise
06 Jan 2025 04:42 PM
RNS
TR-1
31 Dec 2024 07:05 AM
RNS
Grant of Share Options
31 Dec 2024 07:00 AM
RNS
Q-Bot Fundraising
12 Dec 2024 04:49 PM
RNS
TR-1
09 Dec 2024 07:00 AM
RNS
Wanda Health Fundraising
05 Dec 2024 07:00 AM
RNS
Close of Fundraising and Result of Retail Offer
03 Dec 2024 01:24 PM
RNS
Result of Subscription
03 Dec 2024 07:05 AM
RNS
WRAP Retail Offer
03 Dec 2024 07:00 AM
RNS
Proposed Subscription and Retail Offer; Update
14 Nov 2024 03:59 PM
RNS
Replacement RNS: PDS: Update, 3rd Quarter Results
14 Nov 2024 03:23 PM
RNS
PDS: Clinical Programs Update, 3rd Quarter Results
08 Oct 2024 07:00 AM
RNS
Director/PDMR Shareholding
03 Oct 2024 07:00 AM
RNS
Director/PDMR Shareholding
02 Oct 2024 04:38 PM
RNS
PDS: 36-Month Overall Survival Rate announcement
30 Sep 2024 07:00 AM
RNS
Interim Results
26 Sep 2024 07:00 AM
RNS
Name change and AIM Rule 26 website
16 Sep 2024 02:31 PM
RNS
PDS: Updated Results, VERSATILE-002 Phase 2 Trial
13 Aug 2024 03:57 PM
RNS
PDS Biotech: Business Update and Q2 2024 Results
02 Aug 2024 12:21 PM
RNS
Replacement RNS: PDS Biotech Aligns with FDA
02 Aug 2024 07:00 AM
RNS
PDS Biotech Aligns with FDA on Phase 3 Trial
30 Jul 2024 07:00 AM
RNS
Q-Bot Fundraising
10 Jul 2024 10:48 AM
RNS
Result of AGM
18 Jun 2024 07:00 AM
RNS
Notice of AGM
14 Jun 2024 02:10 PM
RNS
TR-1
14 Jun 2024 07:00 AM
RNS
Director/PDMR Shareholding
13 Jun 2024 07:00 AM
RNS
Preliminary Results for the year ended 31 Dec 2023
31 May 2024 07:01 AM
RNS
Notice of Results and Investor Presentation
31 May 2024 07:00 AM
RNS
DeepTech Recycling: Fundraising, Business Update
28 May 2024 07:00 AM
RNS
Investment in Wanda, related party transactions
15 May 2024 02:32 PM
RNS
PDS Biotech: Business Update and Q1 2024 Results
UK 100

Latest directors dealings